Cart
sales@molnova.com
TASP0382088
CAS No. 1253941-85-3
TASP0382088( TASP-0382088 )
Catalog No. M11022 CAS No. 1253941-85-3
A potent, selective ALK5 inhibitor with IC50 of 4.8 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTASP0382088
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective ALK5 inhibitor with IC50 of 4.8 nM.
-
DescriptionA potent, selective ALK5 inhibitor with IC50 of 4.8 nM, >100-fold selectivity over 95 different kinases; inhibits TGF-β-induced Smad2/3 phosphorylation at cellular level with IC50 of 17 nM, inhibits Smad2 phosphorylation in mouse skin after topical application.
-
In Vitro——
-
In Vivo——
-
SynonymsTASP-0382088
-
PathwayTGF-beta/Smad
-
TargetTGFBR
-
RecptorTGFBR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1253941-85-3
-
Formula Weight328.408
-
Molecular FormulaC15H12N4OS2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name7-Methoxy-6-[4-(4-methyl-1,3-thiazol-2-yl)-1H-imidazol-5-yl]-1,3-benzothiazole
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Amada H, et al. Chem Pharm Bull (Tokyo). 2013;61(3):286-91.
molnova catalog
related products
-
Epimedin C
Epimedin C was metabolized via desugarization, dehydrogenation, hydrogenation, dehydroxylation, hydroxylation, demethylation and glucuronidation pathways in vivo.
-
MLN2480
MLN2480 is an oral, selective pan-Raf kinase inhibitor in Clinicalal trials.
-
TASP0382088
A potent, selective ALK5 inhibitor with IC50 of 4.8 nM.
